NEW YORK (GenomeWeb News) – MDS today reported that its second-quarter 2008 revenues rose 24 percent, though only 5 percent excluding the impact of currency exchange and acquisitions.
 
The Toronto-based firm brought in revenues of $326 million for the three-month period ended April 30, compared to $263 million in the comparable period of 2007.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers test gene therapy targeting a different cancer protein in a new trial, the New York Times reports.

Pennsylvania State University researchers found that salivary microRNAs could predict which kids would have longer concussion symptoms, according to NPR.

The Associated Press reports Alex Azar, the new Department of Health and Human Services secretary nominee, made millions of dollars as a pharmaceutical executive.

In PNAS this week: immune profiling of breast cancer, transposable element patterns in rice, and more.